Induction of Fos-like immunoreactivity by opioids in guinea-pig brain

Brain Research

Volumn 731, Issue 1-2, 1996, Pages 45-56

  Bot, G ^a   Chahl, L A ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Brain; Fos; Guinea pig; Morphine; Opioid; Reward; U50,488H

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALTREXONE; OPIATE AGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; FEMALE; GUINEA PIG; IMMUNOCYTOCHEMISTRY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PRIORITY JOURNAL; REWARD; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030603134     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00457-X     Document Type: Article

References (45)

1. [1] Ableitner, A., Contribution of the AMPA glutamate receptor subtype to functional changes in activity produced by the mu opioid agonist DAMGO in limbic forebrain areas. In Proceedings 24th International Narcotics Research Conference, Sweden 1993. Regul. Peptides, suppl. 1 (1994) S39-S40.
2. 14C]-2-deoxyglucose study, Brain Res., 478 (1989) 326-336.
3. [3] Bals-Kubik, R., Ableitner, A.M., Herz, A. and Shippenberg, T.S., Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats, J. Pharmacol. Exp. Ther., 264 (1993) 489-495.
4. [4] Beaver, CJ., Mitchell, D.E. and Robertson, H.A., Immunohistochemical study of the pattern of rapid expression of c-fos protein in the visual cortex of dark-reared kittens following initial exposure to light, J. Comp. Neurol., 333 (1993) 469-484.
5. [5] Bot, G., Chahl, L.A., Brent, P.J. and Johnston, P.A., Effects of intracerebroventricularly administered mu-, delta-and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H. Neuropharmacology, 31 (1992) 825-833.
6. [6] Ceccatelli, S., Villar, MJ., Goldstein, M. and Hokfelt, T., Expression of c-fos immunoreactivity in transmitter-characterized neurons after stress, Proc. Natl. Acad. Sci. USA. 86 (1989) 9569-9573.
7. [7] Chahl, L.A. and Thornton, C., Locomotor activity and contracture of isolated ileum precipitated by naloxone following treatment of guinea-pigs with a single dose of morphine, J. Pharm. Pharmacol., 39 (1987) 52-54.
8. [8] Chang, S.L. and Harlan, R.E., The fos proto-oncogene protein: regulation by morphine in the rat hypothalamus, Life Sci., 46 (1990) 1825-1832.
9. [9] Chang, S.L., Squinto, S.P. and Harlan, R.E., Morphine activation of c-fos expression in rat brain, Biochem. Biophys. Res. Commun., 157 (1988) 698-704.
10. [10] Chang, S.L., Zadina, J.E., Niu, Y.F. and Thompson. J., Morphine modulates IL-1 activation of fos in the rat hypothalamus. In Proceedings 24th INRC, Sweden 1993. Regul. Peptides, suppl. 1 (1994) S265-S266.
11. [11] Chastrette, N., Pfaff, D.W. and Gibbs, R.B., Effects of daytime and nighttime stress on Fos-like immunoreactivity in the paraventricular nucleus of the hypothalamus, the habenula, and the posterior paraventricular nucleus of the thalamus, Brain Res., 563 (1991) 339-334.
12. [12] Cohen, S.R., Kimes, A.S. and London, E.D., Morphine decreases cerebral glucose utilization in limbic and forebrain regions while pain has no effect, Neuropharmacology, 30 (1991) 125-134.
13. [13] Dragunow, M. and Faull, R., The use of c-fos as a metabolic marker in neuronal pathway tracing, J. Neurosci. Methods, 29 (1989) 261-265.
14. [14] Fanselow, M.S., The midbrain periaqueductal gray as a coordinator of action in response to fear and anxiety. In A. Depaulis and A. Bandler (Eds.), The Midbrain Periaqueductal Gray Matter: Functional, Anatomical and Immunohistochemical Organization, Plenum Press, New York, 1991, pp. 151-173.
15. [15] Graeff, F.G., Silveira, M.C.L., Nogueira, R.L., Audi, E.A. and Oliveira, R.M.W., Role of the amygdala and periaqueductal gray in anxiety and panic, Behav. Brain Res., 58 (1993) 123-131.
16. [16] Gu, Y., Conzalez., M.F., Chen, D.Y. and Deutsch, J.A., Expression of c-fos in brain subcortical structures in response to nauseant lithium chloride and osmotic pressure in rats, Neurosci. Lelt., 157 (1993) 49-52.
17. [17] Hai, T. and Curran, T., Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity, Proc. Natl. Acad. Sci. USA. 88, (1991) 3720-3724.
18. [18] Harbuz, M.S. and Lightman, S.L., Stress and the HPA axis: acute, chronic and immune interactions, J. Endocrinol., 134 (1992) 327-339.
19. [19] Hayward, M.D., Duman, R.S. and Nestler, EJ., Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of the rat brain, Brain Res., 525 (1990) 256-266.
20. [20] Heimer, L., Alheid, G.F. and Zahm, D.S., Basal forebrain organization: an anatomical framework for motor aspects of drive and motivation. In P.W. Kalivas and C.D. Barnes (Eds.), Limbic Motor Circuits and Neuropsychiatry, CRC Press, Boca Raton, 1993, pp. 1-93.
21. [21] Herkenham, M. and Nauta, W.J.H., Afferent connections of the habenular nuclei in the rat. A horseradish peroxidase study, with a note on the fiber passage problem, J. Comp. Neurol., 173 (1977) 123-46.
22. [22] Hsu, J.-C., Laz, T., Mohn, K.L. and Taub, R., Identification of LRF-1, a leucine-zipper protein that is rapidly and highly induced in regenerating liver, Proc. Natl. Acad. Sci. USA, 88 (1991) 3511-3515.
23. [23] Hsu, S.M. and Soban, E., Colour modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry, J. Histochem. Cytochem., 30 (1982) 1079-1082.
24. [24] Imaki, T., Shibasaki, T., Hotta, M. and Demura, H., Intracerebroven-tricular administration of corticotropin-releasing factor induces c-fos mRNA expression in brain regions related to stress responses: comparison with pattern of c-fos mRNA induction after stress. Brain Res., 616 (1993) 114-125.
25. [25] Judd, L.L., Hubbard, B., Janowsky, D.S., Hucy, L.Y. and Attewell, P.W., The efects of lithium carbonate on affect, mood, and personality of normal subjects, Arch. Gen. Psychiatry, 34 (1977) 346-351.
26. [26] Katoh, A., Nabeshima, T. and Kameyama, T., Behavioral changes induced by stressful situations: Effects of enkephalins, dynorphin and their interactions, J Pharmacol. Exp. Ther., 253 (1990) 600-607.
27. [27] Koob, G.F. and Bloom, F.E., Cellular and molecular mechanisms of drug dependence, Science, 242 (1988) 715-723.
28. [28] Krylova, O.Y., Shamakina, I.Y. and Anokhin, K.V., Regulation of c-fos expression by acute and chronic morphine administration in rat brain, Neurosci. Res. Commun., 12 (1993) 1133-1140.
29. 1 and N-metnyl-D-aspartate receptors, Proc. Natl. Acad. Sci. USA, 91 (1994) 8537-8541.
30. [30] Mansour, A., Khachaturian, H., Lewis, M.E., Akil, H. and Watson, S.J., Anatomy of CNS opioid receptors, Trends Neurosci., 11 (1988) 308-314.
31. [31] Mansour, A., Schafer, M.K.-H., Newman, S.W. and Watson, S.J., Central distribution of opioid receptors: A cross-species comparison of the multiple opioid system of the basal ganglia. In O.F.X. Almeida and T.S. Shippenberg (Eds.), Neurobiology of Opioids, Springer-Verlag, Berlin, 1991, pp. 169-184.
32. [32] Morgan, J.I. and Curran, T., Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun, Annu. Rev. Neurosci., 14 (1991) 421-452.
33. [33] Nachman, M. and Ashe, J.H., Learned taste aversions in rats as a function of dosage, concentration, and route of administration of LiCI. Physiol. Behav., 10 (1973) 73-78.
34. [34] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates. 2nd edn., Academic Press, Sydney, 1986.
35. [35] Pfeiffer, A., Brantl, V., Hez, A. and Rubin, P.C., Psychotomimesis mediated by κ-opiate receptors, Science, 233 (1986) 774-776.
36. [36] Robson, L.E. Gillan, G.C. and Kosterlitz, H.W., Species differences in the concentrations and distributions of opioid binding sites, Eur. J. Pharmacol., 112 (1985) 65-71.
37. [37] Sandner, G., Oberling, P., Silveira, M.C.L., Di Scala, G., Rocha, B., Bagri, A. and Depoortere, R., What brain structures are active during emotion? Effects of brain stimulation elicited aversion on c-fos immunoreactivity and behavior, Behav. Brain Res., 58 (1993) 9-18.
38. [38] Sharp, F.R., Sager, S.M., Hicks, K., Lowenstein, D. and Hisanaga, K., c-fos mRNA. Fos and Fos-related antigen induction by hypertonic saline and stress, J. Neurosci., 11 (1991) 2321-2331.
39. [39] Shippenberg, T.S., Motivational effects of opioids. In A. Herz (Ed.), Opioids H, Handbook of Experimental Pharmacology, Vol. 104/11, Springer-Verlag, Berlin, 1993, pp. 633-650.
40. [40] Shippenberg, T.S. and Bals-Kubik, R., Motivational effects of opioids: neurochemical and neuroanatomical substrates. In O.F.X. Almedia and T.S. Shippenberg (Eds.), Neurobiology of Opioids, Springer-Verlag, New York, 1991, pp. 331-350.
41. [41] Silveira, M.C.L., Sandner, G. and Graeff, F.G., Induction of Fos immunoreactivity in the rat brain by exposure to the elevated plus-maze, Behav. Brain Res., 56 (1993) 115-118.
42. [42] Stornetta, R.L., Norton, F.E. and Guyenet, P.G., Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats, Brain Res., 624 (1993) 19-28.
43. [43] Watkins, L.R., Wiertelak, E.P. and Maier, S.F., The amygdala is necessary for the expression of conditioned but not unconditioned analgesia, Behav. Neurosci., 107 (1993) 402-405.
44. [44] Yirmiya, R., Ben-Eliyahus., Shavit, Y., Marek, P. and Liebeskind, J.C., Stimulation of the hypothalamic paraventricular nucleus produces analgesia not mediated by vasopressin or endogenous opioids, Brain Res., 537 (1990) 169-174.
45. 2 opioid receptors, Proc. Natl. Acad. Sci. USA, 85 (1988) 4061-4065.